To see the other types of publications on this topic, follow the link: Hypertension clinic.

Journal articles on the topic 'Hypertension clinic'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hypertension clinic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Pierdomenico, Sante D., Franco Cuccurullo, and Andrea Mezzetti. "Isolated clinic hypertension." Journal of Hypertension 16, no. 5 (May 1998): 713–14. http://dx.doi.org/10.1097/00004872-199816050-00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ferrara, L. Aldo, and Aldo Celentano. "Isolated clinic hypertension." Journal of Hypertension 16, no. 5 (May 1998): 714. http://dx.doi.org/10.1097/00004872-199816050-00021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Simper, Anne Marie, and Marianne Hansen. "Nurse-managed hypertension clinic." European Journal of Cardiovascular Prevention & Rehabilitation 13, Supplement 1 (May 2006): S52. http://dx.doi.org/10.1097/00149831-200605001-00210.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Illyés, Miklós, Thomas Mengden, and András Tislér. "The virtual hypertension clinic." Blood Pressure Monitoring 7, no. 1 (February 2002): 67–68. http://dx.doi.org/10.1097/00126097-200202000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

MACDONALD, GRAHAM. "DEATH OF THE HYPERTENSION CLINIC." Australian and New Zealand Journal of Medicine 19, no. 5 (October 1989): 415–16. http://dx.doi.org/10.1111/j.1445-5994.1989.tb00295.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

KHAN, A. "Etiology of refractory hypertension in an urban hypertension clinic." American Journal of Hypertension 12, no. 4 (April 1999): 202. http://dx.doi.org/10.1016/s0895-7061(99)80730-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

SCHULTZ, JANE F., and SHELDON G. SHEPS. "Management of Patients With Hypertension: A Hypertension Clinic Model." Mayo Clinic Proceedings 69, no. 10 (October 1994): 997–99. http://dx.doi.org/10.1016/s0025-6196(12)61829-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schwartz, I. David, and Patrick R. Henderson. "Hypertension/pre-hypertension in a pediatric sub-specialty clinic." Journal of Pediatrics 151, no. 6 (December 2007): e22-e23. http://dx.doi.org/10.1016/j.jpeds.2007.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Covey, Douglas F., Diane D. Shackelford, and Wallace E. Geck. "Pharmacy Services in a Hypertension Clinic." Journal of Pharmacy Practice 5, no. 1 (February 1992): 7–11. http://dx.doi.org/10.1177/089719009200500104.

Full text
Abstract:
Roles for pharmacists are evolving rapidly in the ambulatory care setting. This is primarily due to increasing inpatient costs with a resultant shifting of costs to the outpatient section. This shift has subsequently presented larger numbers of patients and sicker patients to the outpatient setting. This article describes the involvement of a clinical pharmacist in a multidisciplinary hypertension clinic. Detailed are the procedures used to evaluate a patient from consult to discharge, and the responsibilities of the clinical pharmacist, the clinic physician, and the nurse practitioner are reviewed. Finally, methods of documentation and quality assurance are outlined.
APA, Harvard, Vancouver, ISO, and other styles
10

Vinyoles, Ernest, Àngela Felip, Enriqueta Pujol, Alejandro de la Sierra, Rafael Durà, Raquel Hernández del Rey, Javier Sobrino, et al. "Clinical characteristics of isolated clinic hypertension." Journal of Hypertension 26, no. 3 (March 2008): 438–45. http://dx.doi.org/10.1097/hjh.0b013e3282f3150b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Smalley, Lorna. "Nonmedical prescribing: managing a hypertension clinic." Prescriber 18, no. 18 (September 19, 2007): 17–18. http://dx.doi.org/10.1002/psb.127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Cicovic, A., T. McWilliams, H. A. Coverdale, K. Whyte, C. Stewart, and C. A. Wasywich. "Evolution of a Pulmonary Hypertension Clinic." Heart, Lung and Circulation 20, no. 6 (June 2011): 381. http://dx.doi.org/10.1016/j.hlc.2011.03.025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Hassen, Lauren J., Daniel J. Lenihan, and Ragavendra R. Baliga. "Hypertension in the Cardio-Oncology Clinic." Heart Failure Clinics 15, no. 4 (October 2019): 487–95. http://dx.doi.org/10.1016/j.hfc.2019.06.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Chijioke, Chioli, Raphael Anakwue, Teddy Okolo, Esther Ekwe, Chukwuemeka Eze, Charles Agunyenwa, Nnamdi Nwosu, Christopher Amah, Kenneth Nwadike, and Udunma Chijioke. "Awareness, Treatment, and Control of Hypertension in Primary Health Care and Secondary Referral Medical Outpatient Clinic Settings at Enugu, Southeast Nigeria." International Journal of Hypertension 2016 (2016): 1–5. http://dx.doi.org/10.1155/2016/5628453.

Full text
Abstract:
Essential hypertension is the most common noncommunicable disease (NCD), affecting more than half the adult population in many countries and being the major NCD contributor to the double burden of disease in developing countries. We undertook a survey of the hypertension awareness, treatment, and control in primary and secondary referral health care clinics in Enugu, Nigeria, and compared these data with those obtained in local community surveys. The prevalence of hypertension in the primary care clinic (9.2%) was lower than in a previously reported community survey (42.2%), while, in the referral clinic, 70.3% of patients attending were hypertensive. Hypertension awareness rates were 91.9%, 29.4%, and 93.2% in these respective health care settings. Treatment and control rates (89.9% and 72.9%) were better in the secondary care clinic than in the primary care centre (87.7% and 46.0%). (Chi-square analysis confirmed statistically significant differences between these rates (p<0.05).) These data may form a useful index of health care system effectiveness in Nigeria. Possible reasons for the differences observed and effective strategies to address the waxing pandemic of hypertension are discussed.
APA, Harvard, Vancouver, ISO, and other styles
15

Sanz, Jesús, María Paz García‐Vera, Inés Magán, Regina Espinosa, and María Fortún. "Differences in personality between sustained hypertension, isolated clinic hypertension and normotension." European Journal of Personality 21, no. 2 (March 2007): 209–24. http://dx.doi.org/10.1002/per.605.

Full text
Abstract:
The aim of this study was to determine whether there are differences in personality between hypertension and normotension. Forty‐two male patients with essential hypertension were divided into two groups after self‐assessment of blood pressure, 18 with sustained hypertension and 24 with isolated clinic (white coat) hypertension, and were compared with 25 men with normotension on Spielberger's State‐Trait Anxiety Inventory and the Jenkins Activity Survey. In line with hypotheses, the sustained hypertensive group showed higher levels of trait anxiety, Type A behaviour pattern, and hard‐driving behaviours/competitiveness than the normotensive group, whereas isolated clinic hypertensives occupied an intermediate position between those two groups. Results provide support to the hypothesised relationship between personality and hypertension and stress the need of distinguishing sustained hypertension from isolated clinic hypertension. Copyright © 2006 John Wiley & Sons, Ltd.
APA, Harvard, Vancouver, ISO, and other styles
16

Lowe, G. D. O., J. Robertson, F. G. Dunn, A. R. Lorimer, and C. D. Forbes. "Haematocrit in Patients Attending a Hypertension Clinic." Scottish Medical Journal 30, no. 3 (July 1985): 168–72. http://dx.doi.org/10.1177/003693308503000309.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Cuspidi, Cesare, and Gianfranco Parati. "Isolated clinic hypertension in a general population." Journal of Hypertension 24, no. 3 (March 2006): 437–40. http://dx.doi.org/10.1097/01.hjh.0000209976.13488.ad.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Girerd, Barbara, Edmund Lau, David Montani, and Marc Humbert. "Genetics of pulmonary hypertension in the clinic." Current Opinion in Pulmonary Medicine 23, no. 5 (September 2017): 386–91. http://dx.doi.org/10.1097/mcp.0000000000000414.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

KING, D. "Medication adherence in a southeastern hypertension clinic." American Journal of Hypertension 16, no. 5 (May 2003): A234. http://dx.doi.org/10.1016/s0895-7061(03)00715-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Bansal, N. "Blood pressure control in the hypertension clinic." American Journal of Hypertension 16, no. 10 (October 2003): 878–80. http://dx.doi.org/10.1016/s0895-7061(03)01030-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Sinclair, Anne Marie. "Secondary Hypertension in a Blood Pressure Clinic." Archives of Internal Medicine 147, no. 7 (July 1, 1987): 1289. http://dx.doi.org/10.1001/archinte.1987.00370070103015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Sinclair, A. M. "Secondary hypertension in a blood pressure clinic." Archives of Internal Medicine 147, no. 7 (July 1, 1987): 1289–93. http://dx.doi.org/10.1001/archinte.147.7.1289.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Yakovlevitch, M. "Resistant hypertension in a tertiary care clinic." Archives of Internal Medicine 151, no. 9 (September 1, 1991): 1786–92. http://dx.doi.org/10.1001/archinte.151.9.1786.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Yakovlevitch, Marko. "Resistant Hypertension in a Tertiary Care Clinic." Archives of Internal Medicine 151, no. 9 (September 1, 1991): 1786. http://dx.doi.org/10.1001/archinte.1991.00400090078014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Jankowich, Matthew, Ryan Hebel, Jennifer Jantz, Siddique Abbasi, and Gaurav Choudhary. "Multispecialty pulmonary hypertension clinic in the VA." Pulmonary Circulation 7, no. 4 (August 22, 2017): 758–67. http://dx.doi.org/10.1177/2045893217726063.

Full text
Abstract:
Pulmonary hypertension (PH) is often associated with cardiopulmonary co-morbidities, especially in older adults. A multispecialty approach to suspected PH is recommended, but there are few data on adherence to guidelines or outcomes in such patients. This was a single-center retrospective study of consecutively evaluated Veteran patients with suspected PH evaluated in a multispecialty PH clinic at a Veterans Affairs Medical Center, evaluating clinical characteristics, workup outcomes, and prognosis. The referral population (n = 125) was older (mean ± SD age = 73.6 ± 9.8 years) with frequent co-morbidities (e.g. COPD 60%) and obesity (mean ± SD BMI = 32.8 ± 8.1 kg/m2). Of 94 patients undergoing right heart catheterization (RHC), 73 (78%) had confirmed PH (mean pulmonary artery pressure ≥ 25 mmHg). PH was associated with higher BMIs (odds ratio [95% CI] for PH per 1 unit increase = 1.10 [1.02–1.19]) and brachial pulse pressures (odds ratio per 1 mmHg increase = 1.07 [1.02–1.13]). Seventy out of 73 were classifiable by WHO PH groupings. Most patients underwent guideline-recommended PH evaluation. Observed one-year mortality was high (17.8%); the one-year hospitalization rate was 34.2%. These results compare favorably to observations from the VA Clinical Assessment, Reporting, and Tracking cohort of Veterans with PH by RHC (19.1% and 60.9% one-year mortality and hospitalization rates, respectively). Multispecialty PH clinic evaluation revealed a high prevalence of co-morbidities in veterans with suspected PH; PH was prevalent in this referral population. PH patients had significant morbidity and mortality but supportive care measures improved following PH evaluation. Further prospective randomized study is needed to determine if a multispecialty clinic approach improves PH morbidity and mortality in veterans.
APA, Harvard, Vancouver, ISO, and other styles
26

Mengden, Th, S. Ün, A. Tissler, R. Düsing, H. Vetter, and M. Illyés. "The virtual hypertension clinic: telemedicine in the management of arterial hypertension." DMW - Deutsche Medizinische Wochenschrift 126, no. 47 (2001): 1335–41. http://dx.doi.org/10.1055/s-2001-18568.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Kapur, Vinay. "Non-Clinic Blood Pressure Measurement – More Light, Less Darkness." Asian Journal of Medical Sciences 10, no. 1 (December 11, 2018): 13–18. http://dx.doi.org/10.3126/ajms.v10i1.21077.

Full text
Abstract:
Non-clinic blood pressure measurements are very important in confirming diagnosis of hypertension and they give us an idea of associated cardiovascular risk more precisely than clinic BP measurements. It can detect masked hypertension and white coat hypertension & ABPM especially can monitor night-time BP diagnosing individuals with nocturnal hypertension. Masked hypertension and nocturnal hypertension are strongly related with target organ damage along with enhanced morbidity and mortality due to cardiovascular causes. ABPM can also measure early morning rise of BP, mean 24 hour BP, diurnal variation as well as average real variability. Home BP monitoring by patients themselves leads to their greater involvement in maintaining BP records and in achieving treatment goals. The purpose of this review is to preferentially discuss role of non-clinic BP monitoring in making accurate diagnosis and deciding treatment of hypertension that might help a great deal in reducing morbidity and mortality associated with it. Asian Journal of Medical Sciences Vol.10(1) 2019 13-18
APA, Harvard, Vancouver, ISO, and other styles
28

Rimando, PhD, Marylen. "Perceived Barriers to and Facilitators of Hypertension Management among Underserved African American Older Adults." Ethnicity & Disease 25, no. 3 (August 5, 2015): 329. http://dx.doi.org/10.18865/ed.25.3.329.

Full text
Abstract:
<p><strong>Objective: </strong>To understand the perceived barriers to and facilitators of hypertension self-management among underserved Afri­can American older adults in a southeastern clinic.</p><p><strong>Design: </strong>Qualitative descriptive.</p><p><strong>Setting: </strong>Urban cardiovascular health clinic in a southeastern state.</p><p><strong>Participants: </strong>28 African Americans diag­nosed with hypertension.</p><p><strong>Methods: </strong>Interview questions were focused on knowledge of hypertension management and barriers and facilitators to hypertension self-management. Thematic content analysis was applied.</p><p><strong>Results: </strong>Patients reported increased hyper­tension knowledge after attending the clinic. All patients reported knowledge of the severe consequences of uncontrolled hyper­tension. Perceived barriers to hypertension management included lack of money, lack of motivation to exercise, and fear of injury from exercising. Perceived facilitators of hypertension management included weight loss, unexpected diagnosis of hypertension, family members with hypertension and diabetes, and social support.</p><p><strong>Conclusions: </strong>Findings suggest that per­ceived barriers and facilitators influence a patient’s decision to manage hypertension. Findings suggest the importance of health literacy and patient-provider communica­tion at this particular clinic. Possible factors in the social environment may influence hypertension management. This study adds to the literature by understanding the perceived barriers to and facilitators of hy­pertension management of an underserved sample in a southeastern clinic. The results suggest a need for the redesign and trans­formation of future hypertension education strategies aimed at this clinic sample. <em>Ethn Dis. </em>2015;25(3):329-336.</p>
APA, Harvard, Vancouver, ISO, and other styles
29

Goudge, Jane, Tobias Chirwa, Sandra Eldridge, Francesc Xavier F. Gómez-Olivé, Chodziwadziwa Kabudula, Felix Limbani, Eustasius Musenge, and Margaret Thorogood. "Can lay health workers support the management of hypertension? Findings of a cluster randomised trial in South Africa." BMJ Global Health 3, no. 1 (February 2018): e000577. http://dx.doi.org/10.1136/bmjgh-2017-000577.

Full text
Abstract:
IntroductionIn low/middle-income countries with substantial HIV and tuberculosis epidemics, health services often neglect other highly prevalent chronic conditions, such as hypertension, which as a result are poorly managed. This paper reports on a study to assess the effect on hypertension management of lay health workers (LHW) working in South African rural primary healthcare clinics to support the provision of integrated chronic care.MethodsA pragmatic cluster randomised trial with a process evaluation in eight rural clinics assessed the effect of adding two LHWs supporting nurses in providing chronic disease care in each intervention clinic over 18 months. Control clinics continued with usual care. The main outcome measure was the change in the difference of percentage of clinic users who had elevated cardiovascular risk associated with high blood pressure (BP) before and after the intervention, as measured by two cross-sectional population surveys.ResultsThere was no improvement in BP control among users of intervention clinics as compared with control clinics. However, the LHWs improved clinic functioning, including overall attendance, and attendance on the correct day. All clinics faced numerous challenges, including rapidly increasing number of users of chronic care, unreliable BP machines and cuffs, intermittent drug shortages and insufficient space.ConclusionLHWs improved the process of providing care but improved BP control required improved clinical care by nurses which was compromised by large and increasing numbers of patients, the dominance of the vertically funded HIV programme and the poor standards of equipment in clinics.Trial registration numberISRCTN12128227.
APA, Harvard, Vancouver, ISO, and other styles
30

Taj, Fawad, Rehan Zahid, Umm-e.-Rubab Syeda, Muhammed Murtaza, Shahzad Ahmed, and Ayeesha Kamran Kamal. "Risk Factors of Stroke in Pakistan: A Dedicated Stroke Clinic Experience." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37, no. 2 (March 2010): 252–57. http://dx.doi.org/10.1017/s0317167100010015.

Full text
Abstract:
Background:Secondary prevention of cerebrovascular disease through dedicated stroke clinics has been shown to decrease recurrent vascular events in patients. However, there is limited literature describing such stroke clinic experiences from low and middle income countries. This study describes patient characteristics and observations made at the first systematized stroke clinic in Pakistan.Methods:Aretrospective audit of medical records of all patients presenting between September 2006 and August 2008 with a cerebrovascular event was conducted. Information about clinical presentation, modifiable risk factors and laboratory and radiological investigations was collected. Burden of disability was assessed using Modified Rankin score. Data was entered and analyzed using SPSS 14.0.Results:159 patients with a mean age of 57.0 ± 13.9 years were included in this study and 34.6% of all patients were women. 108 patients were diagnosed with ischemic stroke (67.9%) while 34 patients presented with hemorrhagic stroke (21.4%) and 17 patients presented with transient ischemic attacks (10.7%). Hypertension was the most common modifiable risk factor seen in 78.0%, followed by diabetes in 40.3% and dyslipidemia in 31.5%. At presentation to clinic, only 26.0% patients with dyslipidemia and 64.5% patients with hypertension were on appropriate medications.Conclusion:A high prevalence of modifiable risk factors such as hypertension in stroke patients was observed and it presents an opportunity for conventional interventions in Pakistan. Systematized clinics for stroke and an algorithmic approach in primary care towards stroke may improve the implementation of evidence based secondary prevention strategies in developing countries.
APA, Harvard, Vancouver, ISO, and other styles
31

SINGER, G., D. CHUA, J. SETARO, J. FOODY, M. BLUM, and H. BLACK. "Control of hypertension and dyslipidemia are linked in a hypertension specialist clinic." American Journal of Hypertension 18, no. 5 (May 2005): A150—A151. http://dx.doi.org/10.1016/j.amjhyper.2005.03.418.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Dzudie, Anastase, Epie Njume, Liliane Kuate Mfekeu, Armel Djomou, Hamadou Ba, Marie Solange Ndom, Clovis Nkoke, et al. "May Measurement Month 2019: an analysis of blood pressure screening results from Cameroon." European Heart Journal Supplements 23, Supplement_B (May 1, 2021): B33—B36. http://dx.doi.org/10.1093/eurheartj/suab056.

Full text
Abstract:
Abstract The multi-country May Measurement Month (MMM) screening campaign aims to raise awareness on blood pressure (BP) and hypertension in individuals and communities, and measure BP, ideally, of those who had no BP measurement in the preceding year. We here report key findings from the Cameroon arm of MMM 2019. An opportunistic sample of adults (≥18 years) was included from 5 May to 5 June 2019 across 15 sites (markets, churches, homes, motor parks, workplaces, and hospitals/clinics). Data collection, cleaning, the definition of hypertension, and statistical analysis followed the standard protocol. The mean age of the 30 187 participants screened was 36.9 (SD: 14.9) years, 50.4% were female (5% of whom were pregnant), and 94.4% were screened out of the hospital/clinic settings. After multiple imputation of missing data, 6286 (20.8%) had hypertension, 24.0% were taking antihypertensive medication, and 705 (11.2%) of all participants with hypertension had controlled BP. In linear regression models adjusted for age, sex, and antihypertensive medicines use, a previous diagnosis of hypertension, a history of stroke, and use of antihypertensive medicines were significant predictors of systolic and diastolic BP levels. BPs were also significantly higher when measured in public outdoors, public indoors (diastolic BP only), workplaces, and other unspecified areas compared to hospitals/clinic settings. MMM19 is the largest ever BP screening campaign in a single month, in Cameroon and despite the limitations resulting from non-random sample selection, the opportunistic screening allows access to awareness and screening for hypertension out of the hospital/clinic settings.
APA, Harvard, Vancouver, ISO, and other styles
33

ABDRAKHMANOVA, ALSU I., NAIL B. AMIROV, NIKOLAY A. TSIBULKIN, and RAUSHANIA F. GAIFULLINA. "ARTERIAL HYPERTENSION IN PREGNANCY AT INTERNAL MEDICINE CLINIC." Bulletin of Contemporary Clinical Medicine 11, no. 3 (March 2018): 51–59. http://dx.doi.org/10.20969/vskm.2018.11(3).51-59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Siddique, MA, MA Sultan, MM Zaman, MA Rahim, MA Rhamar, SS Al Azad, T. Parvin, and KMHSS Haque. "Metabolic Syndrome Among Hypertension Clinic Patients In Bangladesh." Nepalese Heart Journal 3, no. 3 (December 30, 2004): 57–58. http://dx.doi.org/10.3126/njh.v3i3.26144.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Gill, J. S., A. V. Zezulka, M. Beevers, and D. G. Beevers. "AN AUDIT OF NIFEDIPINE IN A HYPERTENSION CLINIC." Journal of Clinical Pharmacy and Therapeutics 11, no. 2 (April 1986): 107–16. http://dx.doi.org/10.1111/j.1365-2710.1986.tb00834.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Cuspidi, Cesare, Laura Lonati, Lorena Sampieri, Giuseppe Macca, Laura Valagussa, Tiziana Zaro, Iassen Michev, Maurizio Salerno, Gastone Leonetti, and Alberto Zanchetti. "Blood pressure control in a hypertension hospital clinic." Journal of Hypertension 17, no. 6 (June 1999): 835–41. http://dx.doi.org/10.1097/00004872-199917060-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Pierdomenico, S. D., A. Bucci, F. Costantini, D. Lapenna, F. Cuccurullo, and A. Mezzetti. "HEART RATE IN SUSTAINED AND ISOLATED CLINIC HYPERTENSION." Journal of Hypertension 18 (June 2000): S39. http://dx.doi.org/10.1097/00004872-200006001-00122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Verdecchia, Paolo, Paolo Palatini, Giuseppe Schillaci, Paolo Mormino, Carlo Porcellati, and Achille C. Pessina. "Independent predictors of isolated clinic (`white-coat') hypertension." Journal of Hypertension 19, no. 6 (June 2001): 1015–20. http://dx.doi.org/10.1097/00004872-200106000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Mansoor, G. "Herbs and alternative therapies in the hypertension clinic." American Journal of Hypertension 14, no. 9 (September 2001): 971–75. http://dx.doi.org/10.1016/s0895-7061(01)02172-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Teoh, Yee Ping, and John R. Petrie. "Candy in the clinic: resistant hypertension in diabetes." British Journal of Diabetes & Vascular Disease 3, no. 4 (July 2003): 300–301. http://dx.doi.org/10.1177/14746514030030041401.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Ho, T., S. Eason, R. Rahr, and B. Niebuhr. "The Prevalence of Hypertension in a Geriatric Clinic." Journal of the American Academy of Physician Assistants 21, no. 6 (June 2008): 1. http://dx.doi.org/10.1097/01720610-200806000-00068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Thorn, Simon, Jill Bunker, Wendy Callister, Neil Poulter, Peter Sever, and Daphne Zographos. "Multiple risk factor evaluation in a hypertension clinic." Journal of Hypertension 7 (1989): S330–331. http://dx.doi.org/10.1097/00004872-198900076-00161.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Lluberas, Geronimo, Leslie Ann Marie Parrish, and Catherine M. Kling. "Hypertension Prevalence in a Rural Haitian Missionary Clinic." Nurse Practitioner 25, no. 11 (January 2000): 59–61. http://dx.doi.org/10.1097/00006205-200025110-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Smith, A. "Resistant hypertension in a tertiary care clinic: revisited." American Journal of Hypertension 13, no. 6 (June 2000): S112—S113. http://dx.doi.org/10.1016/s0895-7061(00)00539-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Okamoto, Mark P., and Randy K. Nakahiro. "Pharmacoeconomic Evaluation of a Pharmacist-Managed Hypertension Clinic." Pharmacotherapy 21, no. 11 (November 2001): 1337–44. http://dx.doi.org/10.1592/phco.21.17.1337.34424.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Girvin, Briegeen. "Hypertension clinic drug choices: tips for pharmacist prescribers." Prescriber 30, no. 7 (July 2019): 27–30. http://dx.doi.org/10.1002/psb.1776.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Martin, Catherine, James Cameron, and Barry McGrath. "MECHANICAL AND CIRCULATING BIOMARKERS IN ISOLATED CLINIC HYPERTENSION." Clinical and Experimental Pharmacology and Physiology 35, no. 4 (April 2008): 402–8. http://dx.doi.org/10.1111/j.1440-1681.2008.04886.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Kelleher, C., S. M. Kingston, D. G. Barry, M. M. Cole, J. B. Ferriss, G. Grealy, C. Joyce, and D. J. O'Sullivan. "Hypertension in diabetic clinic patients and their siblings." Diabetologia 31, no. 2 (February 1988): 76–81. http://dx.doi.org/10.1007/bf00395551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Kaeser, Martha A., Cheryl Hawk, and Michelle Anderson. "Patient characteristics upon initial presentation to chiropractic teaching clinics: A descriptive study conducted at one university." Journal of Chiropractic Education 28, no. 2 (October 1, 2014): 146–51. http://dx.doi.org/10.7899/jce-14-6.

Full text
Abstract:
Objective The purpose of this study was to compare demographics and chief complaints of the new patient population at our institution's fee-for-service clinics to the patient population of practicing chiropractors in the United States. We also compared the prevalence of obesity and hypertension to reference standards for the adult population. Methods Patient data were obtained from the electronic health records. All records identified as new patients during October 2013 were included. Variables of interest were clinic site, patient demographics, blood pressure, body mass index (BMI), chief complaint, and ICD-9 codes. Descriptive statistics were computed and compared to reference standards from previous reports. Results During October 2013, there were 224 new patients that entered the clinics. The average patient was a 31- to 50-year-old white male. Our clinic patients differed from those seen by US chiropractors in the distribution of all demographic variables. For adult patients, 31.4% were overweight, 29% were obese, and 8% stage 1 or 2 hypertension. Conclusion New patients in the fee-for-service teaching clinics appear to be dissimilar to those of US practicing chiropractors in several important demographics, characteristics, and types of complaints. The new patients had lower levels of overweight, obesity, and hypertension compared to US reference standards.
APA, Harvard, Vancouver, ISO, and other styles
50

Yano, Yuichiro, Anthony J. Viera, Alan L. Hinderliter, Lana L. Watkins, James A. Blumenthal, Kristy S. Johnson, LaBarron K. Hill, and Andrew Sherwood. "Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension." American Journal of Hypertension 33, no. 8 (March 4, 2020): 713–17. http://dx.doi.org/10.1093/ajh/hpaa032.

Full text
Abstract:
Abstract BACKGROUND Masked hypertension (nonhypertensive in the clinic setting but hypertensive outside the clinic during wakefulness) is characterized by increased blood pressure in response to physical and emotional stressors that activate the sympathetic nervous system (SNS). However, no studies have assessed vascular reactivity to a pharmacological SNS challenge in individuals with masked hypertension. METHODS We analyzed data from 161 adults aged 25 to 45 years (mean ± standard deviation age 33 ± 6 years; 48% were African American and 43% were female). Participants completed ambulatory blood pressure monitoring, and a standardized α 1-adrenergic agonist phenylephrine test that determines the dose of phenylephrine required to increase a participant’s mean arterial pressure by 25 mm Hg (PD25). RESULTS Twenty-one participants were considered to have masked hypertension (clinic systolic blood pressure (SBP) &lt;140 and diastolic blood pressure (DBP) &lt;90 mm Hg but awake SBP ≥135 or DBP ≥85 mm Hg), 28 had sustained hypertension (clinic SBP ≥140 or DBP ≥90 mm Hg and awake SBP ≥135 or DBP ≥85 mm Hg), and 106 had sustained normotension (clinic SBP &lt;140 and DBP &lt;90 mm Hg and awake SBP &lt;135 and DBP &lt;85 mm Hg). After multivariable adjustment, the mean (±SE) PD25 was less in participants with masked hypertension compared with their counterparts with sustained normotension (222.1 ± 33.2 vs. 328.7 ± 15.0; P = 0.012), but similar to that observed in subjects with sustained hypertension (254.8 ± 31.0; P =0.12). CONCLUSIONS Among young and middle-aged adults, masked hypertension is associated with increased vascular reactivity to a SNS challenge, which may contribute to elevated awake BPs as well as to increased cardiovascular disease risk.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography